The Vanguard Group 13D/13G Filings for Tonix Pharmaceuticals Holding Corp. (TNXP)

The Vanguard Group 13D and 13G filings for Tonix Pharmaceuticals Holding Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-31
11:31 am
Purchase
2025-09-3013GTonix Pharmaceuticals Holding Corp.
TNXP
The Vanguard Group556,957
6.350%
556,957increase
(New Position)
Filing